GEORGE J. ISHAM, M.D., M.S. (Chair), is currently a Senior Fellow at the HealthPartners Institute in Minneapolis, Minnesota. His areas of interest include understanding how health is created in populations and how to improve health and health care quality and financing. He is formerly a Senior Advisor (2012–2017) and Medical Director and Chief Health Officer (1993–2012) at HealthPartners. He is also currently a Senior Advisor to the Alliance of Community Health Plans and a member of the advisory board for the Center for Health Economics and Policy at FTI Consulting. Dr. Isham is an elected member of the National Academy of Medicine and was designated as a National Associate of the Institute of Medicine in 2003 in recognition of his contribution to its work. He has chaired the National Academies’ Roundtable on Population Health Improvement and the Roundtable on Health Literacy; chaired, served, and been a reviewer for a number of consensus committee reports; and participated in a number of National Academies workshops. Dr. Isham has been active in health policy, serving as a former member of the Centers for Disease Control and Prevention’s (CDC’s) Task Force on Community Preventive Services, as a member of the Agency for Healthcare Research and Quality’s U.S. Preventive Services Task Force, and as a founding co-chair of the National Committee for Quality Assurance’s committee on performance measurement as well as a founding co-chair of the National Quality Forum’s Measurement Application Partnership. He is a founding member
1 The members of the committee serve on the committee as individuals rather than as representatives of their respective organizations.
of the advisory board for the National Guideline Clearinghouse and has served on the Advisory Committee to the Director of CDC.
Dr. Isham earned his Bachelor of Arts in zoology and Master of Science in preventive medicine/administrative medicine from the University of Wisconsin–Madison, and his Doctor of Medicine from the University of Illinois in Chicago. He completed his internship and residency in internal medicine at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin. Dr. Isham has clinical experience as a General Medical Officer in the U.S. Navy, in the general practice of internal medicine at the Freeport Clinic in Freeport, Illinois, and as a Clinical Assistant Professor of Medicine at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin.
L. EBONY BOULWARE, M.D., M.P.H., is a Professor of Medicine, Chief of the Division of General Internal Medicine in the Department of Medicine, Vice Dean for Translational Science, and Associate Vice Chancellor for Translational Research in the School of Medicine at Duke University. She received an A.B. from Vassar College, an M.D. from Duke University, and an M.P.H. from the Johns Hopkins Bloomberg School of Public Health. Dr. Boulware is a general internist and a clinical epidemiologist. She attended medical school at Duke University, completed medical training as a resident and chief resident at the University of Maryland, and completed a research fellowship at the Johns Hopkins University School of Medicine. She became a faculty member in the Johns Hopkins School of Medicine and Bloomberg School of Public Health in 2002, where she achieved the academic rank of Full Professor. In 2013, she was appointed Chief of the Division of General Internal Medicine in the Department of Medicine at Duke University. In 2015, she was appointed the inaugural Director of the Duke Clinical and Translational Science Institute, and she is the contact Principal Investigator for the Duke Clinical and Translational Science Award for Duke University. Dr. Boulware has devoted her scholarly career to studying mechanisms to improve the quality and equity of health care and health outcomes for patients and populations with chronic diseases, such as chronic kidney disease and hypertension. As part of her work, she investigates the influence of attitudinal, social, and environmental contexts on health and health outcomes. She has maintained an active research portfolio throughout her career, funded by the National Institutes of Health, the Patient-Centered Outcomes Research Institute, the Health Resources and Services Administration, the Agency for Healthcare Research and Quality, and several foundations. She has published more than 120 manuscripts, and she has mentored numerous students, fellows, and faculty members in clinical research. Dr. Boulware frequently engages community members, patients, their family members,
and other stakeholders to develop and implement relevant and sustainable interventions to improve health.
GILBERT GEE, Ph.D., is a Professor in the Department of Community Health Sciences at the Fielding School of Public Health at the University of California, Los Angeles. He received his bachelor’s degree in neuroscience from Oberlin College, his doctorate in health policy and management from the Johns Hopkins University, and postdoctoral training in sociology from Indiana University. His research focuses on the social determinants of health inequities of racial, ethnic, and immigrant minority populations using a multilevel and life course perspective. A primary line of his research focuses on conceptualizing and measuring racism discrimination, and in understanding how discrimination may be related to illness. He has also published more broadly on the topics of stress, neighborhoods, environmental exposures, occupational health, and Asian American populations. Current projects include the study of discrimination; racial identity and obesity among emigrants from the Philippines; the relationship between student loans and illness; and toxic exposures among Asian American participants in the National Health and Nutrition Examination Survey. His research has been honored with a group Merit Award from the National Institutes of Health for the development of multicultural measures of discrimination for health surveys. In addition, he received two Scientific and Technical Achievement Awards from the Environmental Protection Agency for development of the Stress-Exposure-Disease Framework.
MARTHE R. GOLD, M.D., M.P.H., is a Senior Scholar at The New York Academy of Medicine and the Logan Professor Emeritus in the Department of Community Health and Social Medicine at the City University of New York Medical School. A graduate of the Tufts University School of Medicine and the Columbia School of Public Health, her clinical training is in family medicine. Dr. Gold has been a primary care provider in urban and rural underserved settings. She served as Senior Policy Adviser in the Office of the Assistant Secretary for Health in the Department of Health and Human Services from 1990 to 1996, where her focus was on financing of clinical preventive services, the economics and outcomes of public health programs, and health care reform. She directed the work of the Panel on Cost-Effectiveness in Health and Medicine, an expert panel whose report remains an influential guide to cost-effectiveness methodology for academic and policy uses. Her current work focuses on patient, public, and decision maker views on using economic and comparative effectiveness information to inform health policy. A member of the National Academy of Medicine, Dr. Gold served as chair of its
Committee on Public Health Strategies to Improve Health (reports published 2010–2012) and has been a member of the Roundtable on Population Health Improvement since its inception.
SHERI JOHNSON, Ph.D. is the Director of the Population Health Institute (PHI) at the University of Wisconsin–Madison, Visiting Associate Professor, and Acting Director, County Health Rankings & Roadmaps, and the Robert Wood Johnson Foundation Culture of Health Prize. For more than 25 years Dr. Johnson has dedicated her career to partnering with children, families, community organizations, and systems to advance health and well-being. Awed by the resilience of individuals and communities, she is motivated to remove unfair obstacles and conditions that create and perpetuate health inequities. Dr. Johnson completed undergraduate studies at Brown University, earned an M.A. and a Ph.D. in clinical psychology at Boston University, and served as a Clinical Fellow in Psychology at the Harvard Medical School. She was previously the Director of Behavioral Health at Milwaukee Health Services, Inc., a federally qualified health center, and served as the Administrator and State Health Officer for the Wisconsin Division of Public Health. Immediately prior to joining the PHI, she was an Associate Professor of Pediatrics at the Medical College of Wisconsin Center for Advancement of Underserved Children, where she collaborated with diverse stakeholders to address a broad range of real-world problems.
PAULA LANTZ, Ph.D., is the Associate Dean for academic affairs and a Professor of public policy at the Ford School. She also holds an appointment as a Professor of health management and policy in the School of Public Health. Dr. Lantz, a social demographer, studies the role of public policy in improving population health. She currently directs the University of Michigan Policies for Action Research Hub, funded by the Robert Wood Johnson Foundation, which is engaged in a number of research projects investigating public policy approaches to reducing social inequities in health. Dr. Lantz is leading a project regarding the potential for and challenges associated with using social impact bonds to fund public–private partnerships aimed at improving population health. An elected member of the National Academy of Social Insurance and the National Academy of Medicine, Dr. Lantz received an M.A. in sociology from Washington University in St. Louis and an M.S. in epidemiology and a Ph.D. in sociology from the University of Wisconsin.
DARCY PHELAN-EMRICK, Dr.P.H., M.H.S., has served as the Chief Epidemiologist at the Baltimore City Health Department since 2015. She leads the Health Department’s efforts to develop and track public health
objectives and goals. Dr. Phelan-Emrick has been a full-time faculty member in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health since 2009, and she holds a joint appointment in the Department of Health, Behavior and Society. She has held prior positions in the New York City Department of Health and Mental Hygiene, The New York Academy of Medicine, and The Rockefeller University. Dr. Phelan-Emrick received her Dr.P.H. in 2009 and M.H.S. in 2005, both in epidemiology, from the Johns Hopkins Bloomberg School of Public Health.
JONATHAN S. SKINNER, Ph.D., is a health economist with experience leading several research projects funded by the National Institute on Aging. These are large-scale interdisciplinary collaborations at Dartmouth and involving partner institutions, drawing on Dartmouth’s comprehensive Medicare and Medicaid datasets. Dr. Skinner’s ongoing research focuses on studying the contribution of “high-tech” health care to cost growth, the diffusion of various types of medical innovations (beneficial and less so), how provider networks affect technology diffusion, and measuring efficiency in health care. A member of the National Academy of Medicine, Dr. Skinner is also a research associate and director of the Aging Program at the National Bureau of Economic Research. He has taught in Dartmouth’s Department of Economics since 1995, where he serves as the James O. Freedman Presidential Professor.
This page intentionally left blank.